Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.

Kandimalla RJ, Wani WY, Anand R, Kaushal A, Prabhakar S, Grover VK, Bharadwaj N, Jain K, Gill KD.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):258-62. doi: 10.1177/1533317513481097.

PMID:
23612909
2.

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.

Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM.

Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15.

PMID:
24633805
3.
4.

Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.

Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G.

J Neurol Sci. 1997 Jan;145(1):33-9.

PMID:
9073026
5.

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T.

Hum Genet. 1995 Jan;95(1):39-42.

PMID:
7814023
6.

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T.

Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74.

PMID:
9850873
7.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
8.

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC.

Exp Neurol. 2003 Sep;183(1):249-53.

PMID:
12957508
9.

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.

Hesse C, Larsson H, Fredman P, Minthon L, Andreasen N, Davidsson P, Blennow K.

Neurochem Res. 2000 Apr;25(4):511-7.

PMID:
10823584
10.

CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.

Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.

Neurosci Lett. 2008 Aug 1;440(2):145-9. doi: 10.1016/j.neulet.2008.05.076. Epub 2008 May 24.

PMID:
18555606
11.

Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.

Mulder M, Ravid R, Swaab DF, de Kloet ER, Haasdijk ED, Julk J, van der Boom JJ, Havekes LM.

Alzheimer Dis Assoc Disord. 1998 Sep;12(3):198-203.

PMID:
9772023
12.

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.

Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A.

Neurobiol Aging. 2011 Dec;32(12):2320.e15-32. doi: 10.1016/j.neurobiolaging.2010.04.028. Epub 2010 Jun 9.

PMID:
20538374
13.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

PMID:
21157024
14.
15.
16.

[Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia].

Paradowski B, Szczepaniak M, Dobosz T, Sasiadek M.

Pol Merkur Lekarski. 2000 Nov;9(53):758-9. Polish.

PMID:
11204323
17.

Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.

Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM.

Ann Neurol. 2000 Aug;48(2):201-10.

PMID:
10939571
18.

Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.

Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart E.

J Neurochem. 1998 Oct;71(4):1643-50.

PMID:
9751198
19.

The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.

Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A.

Neurobiol Aging. 2011 Jul;32(7):1236-48. doi: 10.1016/j.neurobiolaging.2009.07.015. Epub 2009 Aug 26.

PMID:
19713000
20.

Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.

Corbo RM, Gambina G, Ulizzi L, Monini P, Broggio E, Rosano A, Scacchi R.

Dement Geriatr Cogn Disord. 2007;24(2):82-5. Epub 2007 Jun 12.

PMID:
17565217

Supplemental Content

Support Center